Presentations at Leading Neurosurgery Meeting Highlight Benefits of CyberKnife Radiosurgery for the Treatment of CNS Indications
Benefits of Frameless Delivery and Fractionation Demonstrated in Favorable Response Rates and Hearing Preservation
At this year's AANS meeting, doctors presented on their experience treating intracranial tumors and spinal arterial venous malformations (AVMs) with CyberKnife radiosurgery. Key findings include:
--
--
--
These presentations further underscore the unique capabilities of the CyberKnife System, which were recently showcased in a supplement issued by Neurosurgery, the official journal of the Congress of Neurological Surgeons. The supplement, titled "CyberKnife Stereotactic Robotic Radiosurgery", comprised 15 peer-reviewed papers dedicated to CyberKnife radiosurgery experience treating brain and spine indications.
As a non-invasive treatment for intracranial and spinal tumors, the CyberKnife System does not require the use of stabilizing head frames to achieve the sub-millimeter accuracy required for radiosurgery procedures, providing maximum patient comfort. For this reason treatment can easily be delivered in a single fraction or multiple fractions (sessions). This allows the dose to be spread over two to five sessions, which may reduce the risk of damage to sensitive structures such as the cranial nerves, the eyes or the spinal cord. The frameless nature of the CyberKnife System also easily enables treatment of both intracranial tumors and tumors at all levels of the spine.
"CNS applications continue to be an important area for CyberKnife
radiosurgery, with more than 40,000 intracranial and spine patients treated to
date worldwide," said
CyberKnife radiosurgery offers a non-surgical treatment option for benign and cancerous tumors, as well as other conditions such as trigeminal neuralgia and AVMs.
About the CyberKnife(R) Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.
About
Safe Harbor Statement
The foregoing may contain certain forward-looking statements that involve
risks and uncertainties, including uncertainties associated with the medical
device industry. Except for the historical information contained herein, the
matters set forth in this press release, including statements relating to
clinical studies, commercialization of products, and regulatory review and
approval are forward-looking statements within the meaning of the "safe
harbor" provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements speak only as of the date the statements are made
and are based on information available at the time those statements are made
and/or management's good faith belief as of that time with respect to future
events. You should not put undue reliance on any forward-looking statements.
Important factors that could cause actual performance and results to differ
materially from the forward-looking statements we make include: market
acceptance of products; competing products, the combination of our products
with complementary technology; and other risks detailed from time to time
under the heading "Risk Factors" in our report on Form 10-K for the 2008
fiscal year, as updated in our Form 10-Q filed on
Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=85068
SOURCE
CONTACT:
Web Site: http://www.accuray.com